oncology care model

Four oncology treatment advances to watch
Four oncology treatment advances to watchExperts say a cancer care revolution is here. Here’s a closer look at some advancements in cancer treatments to watch.
Unique payer-provider cancer treatment partnershipsUnique partnerships between payers and providers focus on keeping patients out of the hospital and on the road to remission.
Four new treatments for acute myeloid leukemia to watchKey takeaways for healthcare executives from Bruno Medeiros, MD, associate professor of medicine (hematology) at the Stanford University Medical Center and director of Cancer Center Infusion Area Treatment Services at Stanford Cancer Center.
Four new treatments for acute myeloid leukemia to watchKey takeaways for healthcare executives from Bruno Medeiros, MD, associate professor of medicine (hematology) at the Stanford University Medical Center and director of Cancer Center Infusion Area Treatment Services at Stanford Cancer Center.
This is why you should be excited for upcoming cancer researchAcute myeloid leukemia experts share promising new developments on the oncology horizon.
First gene therapy for cancer approved: What health execs should knowThe first therapy based on gene transfer has been approved by the FDA. What’s next for healthcare executives?
Multiple myeloma treatment advances: What health execs should knowIt has been an exciting time at the Myeloma Institute at the University of Arkansas for Medical Sciences, on all fronts, namely, embarking on research that could play an important role in the development of preventative and curative strategies for multiple myeloma in the future.
Innovative strategies help fight multiple myeloma: What every exec should knowAs new scientific advancements occur at the genetic and protein levels, more strategies have been developed to identify and combat multiple myeloma.
Regulatory changes for community oncology: What health execs should knowOne thing that is unlikely to change under the new Administration is the goal of reducing the cost of healthcare through various alternative payment initiatives. Here’s how that will affect oncology.
Gene therapy could be ‘ultimate solution’ for sickle cell diseaseInvestigational gene therapies might reduce the suffering and death caused by this genetic disease.